CANCELLI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 371
NA - Nord America 355
AS - Asia 135
AF - Africa 5
OC - Oceania 1
SA - Sud America 1
Totale 868
Nazione #
US - Stati Uniti d'America 346
IT - Italia 249
SG - Singapore 80
SE - Svezia 34
FI - Finlandia 18
IN - India 16
ID - Indonesia 15
CN - Cina 14
DE - Germania 14
CA - Canada 9
IE - Irlanda 8
BG - Bulgaria 6
NL - Olanda 5
RO - Romania 5
GB - Regno Unito 4
HK - Hong Kong 4
RS - Serbia 4
TG - Togo 4
BE - Belgio 3
GR - Grecia 3
KR - Corea 3
UA - Ucraina 3
CH - Svizzera 2
LU - Lussemburgo 2
PT - Portogallo 2
RU - Federazione Russa 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
FR - Francia 1
HR - Croazia 1
LT - Lituania 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 868
Città #
Rome 92
Singapore 71
Fairfield 42
Chandler 37
Ashburn 27
Santa Clara 22
Helsinki 16
Jakarta 15
Houston 13
Cambridge 12
Seattle 12
Wilmington 12
Milan 11
Woodbridge 11
Naples 10
New York 10
Princeton 10
San Paolo di Civitate 10
Pesaro 9
Dearborn 8
Florence 8
Lawrence 7
San Diego 7
Dublin 6
Sofia 6
Ann Arbor 5
Dallas 5
Toronto 5
Berlin 4
Boston 4
Hangzhou 4
Hong Kong 4
Lomé 4
Millbury 4
San Mateo 4
Belgrade 3
Biancavilla 3
Boardman 3
Chennai 3
Chicago 3
Fiuggi 3
Lucca 3
Verona 3
Amsterdam 2
Andover 2
Aosta 2
Athens 2
Bari 2
Beijing 2
Bern 2
Bremen 2
Catania 2
Civitavecchia 2
Des Moines 2
Edmonton 2
Empoli 2
Fremont 2
Hyderabad 2
Lappeenranta 2
Leuven 2
Macerata 2
Nanchang 2
Norwalk 2
Piacenza 2
Plano 2
Porto 2
Rodano 2
Albano Laziale 1
Ardea 1
Brno 1
Brussels 1
Bühl 1
Castiglione Olona 1
Changsha 1
Chieti 1
Cologne 1
Dearborn Heights 1
Falkenstein 1
Frankfurt am Main 1
Gdynia 1
Gozzano 1
Groningen 1
Guangzhou 1
Ischia di Castro 1
Islington 1
Kilburn 1
Kragujevac 1
Leander 1
Los Angeles 1
Marseille 1
Melbourne 1
Modena 1
Montréal 1
Moscow 1
Muizenberg 1
Novara 1
Ottawa 1
Phoenix 1
Piraeus 1
Qinzhou 1
Totale 632
Nome #
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value 94
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection 80
Role of double-carbapenem regimen in the treatment of infections due to carbapenemase producing carbapenem-resistant enterobacteriaceae: a single-center, observational study 74
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature 74
Curb-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with sars-cov-2 pneumonia 66
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies. Results from the HM-COV 2.0 study 54
Real-life experience in the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series 53
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations 49
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature 49
Low-grade endotoxemia and thrombosis in COVID-19 46
Effect of n-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii. A retrospective case-control study 38
Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19 38
Challenges in the Clinical Management of {SARS}-{CoV}2-Infected Patients with Haematological Malignancies 30
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections. A single-center preliminary experience 29
Role of serum e-selectin as a biomarker of infection severity in coronavirus disease 2019 28
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study 25
null 24
Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19 19
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study 18
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems. A multicentric propensity score-weighted observational cohort study 16
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study 12
null 10
null 7
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study 7
null 5
Totale 945
Categoria #
all - tutte 4.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 7 8 4 4 3 2 7
2020/202177 2 2 0 2 4 10 0 0 29 10 6 12
2021/2022129 8 10 6 11 9 5 3 6 16 1 32 22
2022/2023185 22 31 23 16 14 14 1 17 17 2 15 13
2023/2024196 12 15 8 10 12 22 14 28 6 31 18 20
2024/2025262 10 51 33 73 43 52 0 0 0 0 0 0
Totale 945